Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising usage of primary cell culture products in in-vitro testing
3.2.1.2 Increasing prevalence of cancer and other persistent health conditions
3.2.1.3 Growing advancement in genetic engineering protocols
3.2.1.4 Increase in funding for functional biology and research
3.2.2 Industry pitfalls & challenges
3.2.2.1 Ethical and regulatory concerns related to the use of primary cells
3.2.2.2 Limitations associated with primary cells
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Cell Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Animal cells
5.3 Human cells
Chapter 6 Market Estimates and Forecast, By Component, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Products
6.2.1 Blood cell
6.2.2 Nerve cell
6.2.3 Bone marrow
6.2.4 Endothelial cell
6.2.5 Skin cell
6.2.6 Muscle cell
6.2.7 Other cell types
6.3 Media
6.4 Reagents & supplements
6.4.1 Cell dissociation and cell attachment solutions
6.4.2 Buffers and salts
6.4.3 Cell freezing media
6.4.4 Sera, growth factors & cytokines
6.4.5 Other reagents & supplements
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Drug screening and toxicity testing
7.3 Vaccine production
7.4 Cell & gene therapy development
7.5 Regenerative medicine
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Research institutes and academic laboratories
8.4 Contract research organizations (CROs)
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 BioLamina AB
10.2 Corning Incorporated
10.3 Creative Bioarray
10.4 Cyagen
10.5 FUJIFILM Wako Pure Chemical Corporation
10.6 Kosheeka
10.7 Lifeline Cell Technology,
10.8 Lonza Bioscience
10.9 Merck KGaA
10.10 PELOBIOTECH GmbH
10.11 PromoCell GmbH
10.12 STEMCELL Technologies
10.13 Thermo Fisher Scientific Inc.
